Treatment of sleep disorders using CNS target modulators
US7189757B2 · kind B2 · utility
1Cited by
28References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 2002 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | Jan 27, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to compositions used for treating Central Nervous System (CNS) disorders. In addition, the invention provides convenient methods of treatment of a CNS disorder. Furthermore, the invention provides methods of treating sleep disorders using compositions that remain active for a discrete period of time to reduce side effects. More specifically, the invention is directed to the compositions and use of derivatized, e.g., ester or carboxylic acid derivatized, antihistamine antagonists for the treatment of sleep disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.